scholarly journals The effects of aloe emodin-mediated antimicrobial photodynamic therapy on drug-sensitive and resistant Candida albicans

2020 ◽  
Vol 19 (4) ◽  
pp. 485-494 ◽  
Author(s):  
Wenpeng Ma ◽  
Chengcheng Liu ◽  
Jiao Li ◽  
Ming Hao ◽  
Yanhong Ji ◽  
...  

Aloe emodin-mediated antimicrobial photodynamic therapy effectively inactivated drug-sensitive and resistant C. albicans and caused damage to the cell wall, cytoplasm, and nucleus.

2019 ◽  
Vol 27 ◽  
pp. 124-131 ◽  
Author(s):  
Beatriz H.D. Panariello ◽  
Marlise I. Klein ◽  
Fernanda Alves ◽  
Ana Cláudia Pavarina

2021 ◽  
Vol 8 ◽  
Author(s):  
Thomas Voit ◽  
Fabian Cieplik ◽  
Johannes Regensburger ◽  
Karl-Anton Hiller ◽  
Anita Gollmer ◽  
...  

The antimicrobial photodynamic therapy (aPDT) is a promising approach for the control of microbial and especially fungal infections such as mucosal mycosis. TMPyP [5,10,15, 20-tetrakis(1-methylpyridinium-4-yl)-porphyrin tetra p-toluenesulfonate] is an effective photosensitizer (PS) that is commonly used in aPDT. The aim of this study was to examine the localization of TMPyP in Candida albicans before and after irradiation with visible light to get information about the cellular mechanism of antifungal action of the photodynamic process using this PS. Immediately after incubation of C. albicans with TMPyP, fluorescence microscopy revealed an accumulation of the PS in the cell envelope. After irradiation with blue light the complete cell showed red fluorescence, which indicates, that aPDT is leading to a damage in the cell wall with following influx of PS into the cytosol. Incubation of C. albicans with Wheat Germ Agglutinin (WGA) could confirm the cell wall as primary binding site of TMPyP. The finding that the porphyrin accumulates in the fungal cell wall and does not enter the interior of the cell before irradiation makes it unlikely that resistances can emerge upon aPDT. The results of this study may help in further development and modification of PS in order to increase efficacy against fungal infections such as those caused by C. albicans.


2019 ◽  
Vol 12 (3) ◽  
pp. 140 ◽  
Author(s):  
Karem Janeth Rimachi Hidalgo ◽  
Juliana Cabrini Carmello ◽  
Cláudia Carolina Jordão ◽  
Paula Aboud Barbugli ◽  
Carlos Alberto de Sousa Costa ◽  
...  

Background: It has been demonstrated that azole-resistant strains of Candida albicans have a greater resistance to antimicrobial photodynamic therapy (aPDT) when compared to their more susceptible counterparts. For this reason, the present study evaluated the efficacy of aPDT, together with nystatin (NYS), in the treatment of oral candidiasis in vivo. Methods: Mice were infected with fluconazole-resistant C. albicans (ATCC 96901). To perform the combined therapy, aPDT, mediated by Photodithazine (PDZ) and LED light, was used together with NYS. The efficacy of the treatments was evaluated by microbiological, macroscopic, histopathological and Confocal Scanning Laser Microscopy analyses of the lesions. The expression of p21 and p53, proteins associated with cell death, from the tongues of mice, was also performed. Results: The combined therapy reduced the fungal viability by around 2.6 log10 and decreased the oral lesions and the inflammatory reaction. Additionally, it stimulated the production of p53 and p21. Conclusions: The combined therapy is a promising alternative treatment for oral candidiasis induced by C. albicans resistant to fluconazole.


Author(s):  
Marisa Lopes ◽  
Carlos Tiago Alves ◽  
B. Rama Raju ◽  
M. Sameiro T. Gonçalves ◽  
Paulo J.G. Coutinho ◽  
...  

2016 ◽  
Vol 31 (4) ◽  
pp. 605-610 ◽  
Author(s):  
Michelle Peneluppi Silva ◽  
Thais Alves dos Santos ◽  
Patrícia Pimentel de Barros ◽  
Felipe de Camargo Ribeiro ◽  
Juliana Campos Junqueira ◽  
...  

Author(s):  
Joyce da Silva Martins ◽  
Juliana Campos Junqueira ◽  
Raquel Lourdes Faria ◽  
Naiara Fonseca Santiago ◽  
Rodnei Dennis Rossoni ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document